🚨 $AGMB
Epstein David R (Insider) bought 15,000 shares at an average price of $6.9000 per common share. (Date: 2026-11-05)
Epstein David R (Insider) bought 15,000 shares at an average price of $6.9000 per common share. (Date: 2026-11-05)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
November 6, 2026 at 11:39 AM
🚨 $AGMB
Epstein David R (Insider) bought 15,000 shares at an average price of $6.9000 per common share. (Date: 2026-11-05)
Epstein David R (Insider) bought 15,000 shares at an average price of $6.9000 per common share. (Date: 2026-11-05)
Good riddance mikey johnson.
Hakeem, we need a warrior as Speaker of the House. Be that warrior for the 99% of US. @hakeem-jeffries.bsky.social
www.youtube.com/watch?v=AGmB...
Hakeem, we need a warrior as Speaker of the House. Be that warrior for the 99% of US. @hakeem-jeffries.bsky.social
www.youtube.com/watch?v=AGmB...
Maddow: 'SEISMIC CHANGE' as Democrats retake House control
YouTube video by MS NOW
www.youtube.com
November 4, 2026 at 4:28 AM
Good riddance mikey johnson.
Hakeem, we need a warrior as Speaker of the House. Be that warrior for the 99% of US. @hakeem-jeffries.bsky.social
www.youtube.com/watch?v=AGmB...
Hakeem, we need a warrior as Speaker of the House. Be that warrior for the 99% of US. @hakeem-jeffries.bsky.social
www.youtube.com/watch?v=AGmB...
November 5, 2026 at 1:01 AM
I'm getting more and more excited by the US midterms as the night progresses and more results come in!
www.youtube.com/watch?v=AGmB...
www.youtube.com/watch?v=AGmB...
Maddow: 'SEISMIC CHANGE' as Democrats retake House control
YouTube video by MS NOW
www.youtube.com
November 4, 2026 at 4:14 AM
I'm getting more and more excited by the US midterms as the night progresses and more results come in!
www.youtube.com/watch?v=AGmB...
www.youtube.com/watch?v=AGmB...
AgomAb Therapeutics ($AGMB) – Insider Purchase
• Insider: David R Epstein, Director
• Bought: 15,000 shares (about $104K)
• Price: about $6.90 a share · Nov 5
• Now Holds: 40,000 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: David R Epstein, Director
• Bought: 15,000 shares (about $104K)
• Price: about $6.90 a share · Nov 5
• Now Holds: 40,000 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
David R Epstein (Director) bought $104K of AgomAb Therapeutics ($AGMB)
Form 4 filed Nov 6. Every line of the filing.
elixstocks.com
November 6, 2026 at 12:24 PM
AgomAb Therapeutics ($AGMB) – Insider Purchase
• Insider: David R Epstein, Director
• Bought: 15,000 shares (about $104K)
• Price: about $6.90 a share · Nov 5
• Now Holds: 40,000 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: David R Epstein, Director
• Bought: 15,000 shares (about $104K)
• Price: about $6.90 a share · Nov 5
• Now Holds: 40,000 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
Jeffries is NOT A FIGHTER. He supports the "status quo." And he takes money from AIPAC and gives them favors. Him and Schumer ought to step down and out.
www.youtube.com/watch?v=AGmB...
www.youtube.com/watch?v=AGmB...
Maddow: 'SEISMIC CHANGE' as Democrats retake House control
YouTube video by MS NOW
www.youtube.com
November 4, 2026 at 4:30 AM
Jeffries is NOT A FIGHTER. He supports the "status quo." And he takes money from AIPAC and gives them favors. Him and Schumer ought to step down and out.
www.youtube.com/watch?v=AGmB...
www.youtube.com/watch?v=AGmB...
#ElectionDoomsday in America seems far from over, as races are still undecided for the Senate and the House. Nonetheless, watch this special Midterm edition of the #DailyThread🧵 to make you smile.
#KlicKNet www.youtube.com/watch?v=AGmB...
#KlicKNet www.youtube.com/watch?v=AGmB...
Maddow: 'SEISMIC CHANGE' as Democrats retake House control
YouTube video by MS NOW
www.youtube.com
November 4, 2026 at 7:56 PM
#ElectionDoomsday in America seems far from over, as races are still undecided for the Senate and the House. Nonetheless, watch this special Midterm edition of the #DailyThread🧵 to make you smile.
#KlicKNet www.youtube.com/watch?v=AGmB...
#KlicKNet www.youtube.com/watch?v=AGmB...
Trading Resumed for $AGMB AgomAb Therapeutics NV ADS | at 09:48:58 ET on NASDAQ | 2026-10-30
October 30, 2026 at 1:52 PM
Trading Resumed for $AGMB AgomAb Therapeutics NV ADS | at 09:48:58 ET on NASDAQ | 2026-10-30
Trading Halted for $AGMB AgomAb Therapeutics NV ADS | at 09:38:58.663 ET on NASDAQ | Volatility Trading Pause | 2026-10-30
October 30, 2026 at 1:43 PM
Trading Halted for $AGMB AgomAb Therapeutics NV ADS | at 09:38:58.663 ET on NASDAQ | Volatility Trading Pause | 2026-10-30
AgomAb Therapeutics NV insider buying: director Epstein David R bought $44K of $AGMB stock in open-market trades.
Filing details: https://capitalsnitch.com/stock/AGMB
Not financial advice.
The C-suite left a paper trail. We read it for you. CapitalSnitch.
#InsiderBuying #stocks #investing
Filing details: https://capitalsnitch.com/stock/AGMB
Not financial advice.
The C-suite left a paper trail. We read it for you. CapitalSnitch.
#InsiderBuying #stocks #investing
AGMB insider trading, Congress trades & who owns it · CapitalSnitch
Every SEC insider buy and sale in AGMB, fund ownership and Congress trades, updated daily.
capitalsnitch.com
October 22, 2026 at 1:50 PM
AgomAb Therapeutics NV insider buying: director Epstein David R bought $44K of $AGMB stock in open-market trades.
Filing details: https://capitalsnitch.com/stock/AGMB
Not financial advice.
The C-suite left a paper trail. We read it for you. CapitalSnitch.
#InsiderBuying #stocks #investing
Filing details: https://capitalsnitch.com/stock/AGMB
Not financial advice.
The C-suite left a paper trail. We read it for you. CapitalSnitch.
#InsiderBuying #stocks #investing
#$AGMB AgomAb Therapeutics
Director David R Epstein bought $88,800 of shares on 21 Oct (SEC filing, 22 Oct).
Holding +67%
Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
Director David R Epstein bought $88,800 of shares on 21 Oct (SEC filing, 22 Oct).
Holding +67%
Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
Real insider buys, last 5 trading days · Chalni
Top managers and directors buying their own company's shares, from SEC Form 4 filings. Pay plans, funds, pre-planned trades and private deals removed.
chalni.com
October 23, 2026 at 11:53 AM
#$AGMB AgomAb Therapeutics
Director David R Epstein bought $88,800 of shares on 21 Oct (SEC filing, 22 Oct).
Holding +67%
Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
Director David R Epstein bought $88,800 of shares on 21 Oct (SEC filing, 22 Oct).
Holding +67%
Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
🚨 $AGMB
Epstein David R (Insider) bought 10,000 shares at an average price of $8.8800 per common share. (Date: 2026-10-21)
Epstein David R (Insider) bought 10,000 shares at an average price of $8.8800 per common share. (Date: 2026-10-21)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 22, 2026 at 12:15 PM
🚨 $AGMB
Epstein David R (Insider) bought 10,000 shares at an average price of $8.8800 per common share. (Date: 2026-10-21)
Epstein David R (Insider) bought 10,000 shares at an average price of $8.8800 per common share. (Date: 2026-10-21)
AgomAb Therapeutics ($AGMB) – Insider Purchase
• Insider: David R Epstein, Director
• Bought: 10,000 shares (about $89K)
• Price: about $8.88 a share · Oct 21
• Filed: Oct 22 · Form 4
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: David R Epstein, Director
• Bought: 10,000 shares (about $89K)
• Price: about $8.88 a share · Oct 21
• Filed: Oct 22 · Form 4
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
David R Epstein (Director) bought $89K of AgomAb Therapeutics ($AGMB)
Form 4 filed Oct 22. Every line of the filing.
elixstocks.com
October 22, 2026 at 12:15 PM
AgomAb Therapeutics ($AGMB) – Insider Purchase
• Insider: David R Epstein, Director
• Bought: 10,000 shares (about $89K)
• Price: about $8.88 a share · Oct 21
• Filed: Oct 22 · Form 4
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: David R Epstein, Director
• Bought: 10,000 shares (about $89K)
• Price: about $8.88 a share · Oct 21
• Filed: Oct 22 · Form 4
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
$AGMB: CEO Tim Jasper Knotnerus of AgomAb Therapeutics NV reported purchasing $94k of shares on Oct 6. Activity Score 42/100.
https://yarako.com/insider-buying/AGMB
Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
https://yarako.com/insider-buying/AGMB
Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
$AGMB insider purchases on Yarako
Open-market insider purchases reported on SEC Form 4. Information only, not advice.
yarako.com
October 20, 2026 at 2:07 PM
$AGMB: CEO Tim Jasper Knotnerus of AgomAb Therapeutics NV reported purchasing $94k of shares on Oct 6. Activity Score 42/100.
https://yarako.com/insider-buying/AGMB
Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
https://yarako.com/insider-buying/AGMB
Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
#AGMB Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
https://www.stocktitan.net/news/AGMB/agomab-announces-first-patient-dosed-in-global-nov-era-phase-2b-ay0gg07817ba.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AGMB/agomab-announces-first-patient-dosed-in-global-nov-era-phase-2b-ay0gg07817ba.html?utm_source=stocktitan-bluesky&utm_medium=social
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 13, 2026 at 8:05 PM
#AGMB Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
https://www.stocktitan.net/news/AGMB/agomab-announces-first-patient-dosed-in-global-nov-era-phase-2b-ay0gg07817ba.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AGMB/agomab-announces-first-patient-dosed-in-global-nov-era-phase-2b-ay0gg07817ba.html?utm_source=stocktitan-bluesky&utm_medium=social
Cluster buy: 3 insiders at AgomAb Therapeutics NV ($AGMB) bought $311K of stock, including the CEO.
Their avg. price $8.64. Stock now $9.08 (+5.0%).
https://www.insiderprint.com/ticker/AGMB?utm_source=bluesky&utm_medium=social&utm_campaign=cluster
#InsiderBuying #Healthcare
Their avg. price $8.64. Stock now $9.08 (+5.0%).
https://www.insiderprint.com/ticker/AGMB?utm_source=bluesky&utm_medium=social&utm_campaign=cluster
#InsiderBuying #Healthcare
AgomAb Therapeutics NV (AGMB) insider buying
3 insiders bought $311K.
www.insiderprint.com
October 11, 2026 at 4:01 AM
Cluster buy: 3 insiders at AgomAb Therapeutics NV ($AGMB) bought $311K of stock, including the CEO.
Their avg. price $8.64. Stock now $9.08 (+5.0%).
https://www.insiderprint.com/ticker/AGMB?utm_source=bluesky&utm_medium=social&utm_campaign=cluster
#InsiderBuying #Healthcare
Their avg. price $8.64. Stock now $9.08 (+5.0%).
https://www.insiderprint.com/ticker/AGMB?utm_source=bluesky&utm_medium=social&utm_campaign=cluster
#InsiderBuying #Healthcare
🚨 $AGMB
Epstein David R (Insider) bought 5,000 shares at an average price of $8.9000 per common share. (Date: 2026-10-08)
Epstein David R (Insider) bought 5,000 shares at an average price of $8.9000 per common share. (Date: 2026-10-08)
SEC Filing: AGMB
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 12:02 PM
🚨 $AGMB
Epstein David R (Insider) bought 5,000 shares at an average price of $8.9000 per common share. (Date: 2026-10-08)
Epstein David R (Insider) bought 5,000 shares at an average price of $8.9000 per common share. (Date: 2026-10-08)
Epstein David R, Director at $AGMB, raised their own stake by 50% — bought 5,000 shares (~$45K) on the open market.
https://insiderbid.com/insider/0001445826
https://insiderbid.com/insider/0001445826
October 9, 2026 at 12:04 PM
Epstein David R, Director at $AGMB, raised their own stake by 50% — bought 5,000 shares (~$45K) on the open market.
https://insiderbid.com/insider/0001445826
https://insiderbid.com/insider/0001445826
AgomAb Therapeutics ($AGMB): Director buys shares
David R Epstein: +5,000 shares (about $44K)
About $8.90 a share · Oct 8
3 insiders bought in the last 30 days
SEC Form 4 · filed Oct 9
#InsiderBuying #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
David R Epstein: +5,000 shares (about $44K)
About $8.90 a share · Oct 8
3 insiders bought in the last 30 days
SEC Form 4 · filed Oct 9
#InsiderBuying #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
David R Epstein (Director) bought $44K of AgomAb Therapeutics ($AGMB)
Form 4 filed Oct 9. Every line of the filing.
elixstocks.com
October 9, 2026 at 12:43 PM
AgomAb Therapeutics ($AGMB): Director buys shares
David R Epstein: +5,000 shares (about $44K)
About $8.90 a share · Oct 8
3 insiders bought in the last 30 days
SEC Form 4 · filed Oct 9
#InsiderBuying #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
David R Epstein: +5,000 shares (about $44K)
About $8.90 a share · Oct 8
3 insiders bought in the last 30 days
SEC Form 4 · filed Oct 9
#InsiderBuying #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
CFO of $AGMB just bought $26K CFO insider buys average +2.75% excess returns at 7 days (n=1,528, t=8.41).
October 7, 2026 at 6:00 PM
CFO of $AGMB just bought $26K CFO insider buys average +2.75% excess returns at 7 days (n=1,528, t=8.41).